Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Descompressive Craniectomy. - Trial NCT03221959
Access comprehensive clinical trial information for NCT03221959 through Pure Global AI's free database. This phase not specified trial is sponsored by Kienzler Jenny and is currently status unknown. The study focuses on Intracranial Pressure Increase. Target enrollment is 48 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Kienzler Jenny
Kantonsspital Aarau
Timeline & Enrollment
N/A
Jan 01, 2018
Dec 01, 2020
Primary Outcome
non-invasive ICP) measurement im mmHg
Summary
This is a single centre, observational study with a medical device which has Conformité
 Européenne (CE) marking. The aim of the study is to demonstrate that patients with malignant
 middle cerebral artery infarction (M-MCA) show an increased intra-cranial pressure (ICP)
 compared to neurological patients without M-MCA infarction or other space-occupying
 indications.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03221959
Device Trial